Association between a polymorphism in cysteinyl leukotriene receptor 2 on chromosome 13q14 and atopic asthma.

Pharmacogenetics

Department of Medical Genetics, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, 305-8575, Japan.

Published: October 2004

Objective: Cysteinyl leukotriene receptor 2 (CYSLTR2) is one of the receptors for the cysteinyl leukotrienes (CYSLTs), which cause bronchoconstrictions, vascular hyperpermeability and mucus hypersecretion in asthmatic patients. CYSLTR1 antagonists have been shown to be effective in the treatment of chronic asthma. CYSLTR2 is located approximately 300 kb from D13S153, which is reportedly linked to asthma in several populations. We characterized the genomic structure of humans CYSLTR2, determined the putative major promoter region and conducted association studies pertaining to polymorphisms in CYSLTR2 and asthma.

Methods And Results: We identified three novel exons in the 5' untranslated region of CYSLTR2 by rapid amplification of cDNA ends and identified eight novel polymorphisms in CYSLTR2 by direct sequencing. A transmission disequilibrium test with 137 Japanese asthmatic families revealed that the -1220A > C polymorphism is associated with the development of asthma (P = 0.0066). In addition, a polymorphism in the putative promoter region caused different promoter activities in vitro.

Conclusion: Our results suggest that CYSLTR2 is one of the genes that contributes to susceptibility to asthma in the Japanese population.

Download full-text PDF

Source
http://dx.doi.org/10.1097/00008571-200410000-00006DOI Listing

Publication Analysis

Top Keywords

cysteinyl leukotriene
8
leukotriene receptor
8
promoter region
8
polymorphisms cysltr2
8
cysltr2
7
asthma
5
association polymorphism
4
polymorphism cysteinyl
4
receptor chromosome
4
chromosome 13q14
4

Similar Publications

The two most clinically important members of the flavivirus genus, Zika virus (ZIKV) and dengue virus (DENV) pose a significant public health challenge. They cause a range of diseases in humans, from hemorrhagic to neurological manifestations, leading to economic and social burden worldwide. Nevertheless, there are no approved antiviral drugs to treat these infections.

View Article and Find Full Text PDF

Montelukast potentiates the relaxing effect of nifedipine in the porcine myometrium.

Pol J Vet Sci

September 2024

Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Oczapowskiego 13, 10-718 Olsztyn, Poland.

This study analysed the influence of montelukast (MON), a cysteinyl leukotriene receptor antagonist, and nifedipine, an L-type voltage-gated Ca2+ channel blocker, on the contractility of the porcine uterine smooth muscle. Myometrial strips were collected from the sexually immature (n=8), cyclic (12-14 days of the oestrous cycle; n=8) and pregnant (27-28 days of pregnancy; n=8) gilts and stimulated with a) MON or nifedipine at concentrations of 10-8-10-4 M and b) increasing concentrations of nifedipine after previous administration of MON at a concentration of 10-4 M. The changes in the tension, amplitude and frequency of contractions were determined with the Hugo Sachs Elektronik equipment for measuring isometric contractions.

View Article and Find Full Text PDF

Purpose: Diabetic macular edema (DME) is the primary cause of vision impairment in diabetic retinopathy (DR) patients. A previous study has shown the efficacy of montelukast, a cysteinyl leukotriene receptor (CysLTR)1 antagonist, in a diabetic mouse model. This study aims to understand the CysLTR1 signaling in retinal endothelial cells and the impact of montelukast.

View Article and Find Full Text PDF
Article Synopsis
  • * This study examined how benzyl alcohol impacts the immune defense systems of wax moths, revealing significant changes in their cuticular lipid composition and immune responses.
  • * Findings suggest that benzyl alcohol not only boosts certain protective proteins but also negatively affects insect cells, highlighting its potential as a non-toxic insecticide for vertebrates.
View Article and Find Full Text PDF
Article Synopsis
  • * The study investigates the expression of the CYSLTR1 receptor in 31 human UM samples and shows that it is highly expressed in both primary and metastatic UM cells.
  • * Blocking CYSLTR1 with the drug MK571 reduces UM cell growth and metabolic activity while increasing cell death, suggesting that targeting this receptor could be a promising treatment strategy for UM.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!